Premium Information is available for this item - Upgrade for $1 a day
6505-01-364-2271
Usp Zalcitabine Tablets
6505013642271 013642271 77252 NDC00004-0220-01
INC: 66774 Zalcitabine Tablets
January 2023
6
Marketplace 6505-01-364-2271
Request a Quotation from participating marketplace vendors
Related Documents 6505-01-364-2271 5+ Documents (More...)
RQST NE Updated Every Day 6505-01-364-2271 RQST Updated Every Day 6505-01-364-2271 RQST NE Related
Documents 6505-01-364-2271 5+ Documents ( More... ) https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505
4125 6505-01-364-2272 https//www.nsnlookup.com https / /www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-364-2271
6505013642272,77255 Tablets6505013644124 013644124 NDC00004-0221-01 Usp www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-364-2271
Upgrade your Account Upgrade 6505-01-364-4125Usp https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-364-2271
Zalcitabine Tablets6505013644125 013644125HIVID NDC00004 Card Assembly5998995234523 995234523 C30-77252
6505013642271,77252 01-364-2272 https//www.nsnlookup.com https/ /www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-364-2271
Stock Numbers Related to 6505-01-364-4124 6505-01-364-4124 6505-01-364-4125 6505-01-364-2272 6505-01-364-2271
JavaScript in your web browser . 5998-99-523-4523Circuit Card Assembly5998995234523 995234523 C30-77252
JavaScript in your web browser . 5998-99-523-4523Circuit Card Assembly5998995234523 995234523 C30-77252
Restrictions 6505-01-364-2271
6505-01-364-2271 is a Usp Zalcitabine Tablets that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. The precious metals content of this item is unknown.
Import and Export 6505-01-364-2271
- Schedule B
- Subscribe to View Schedule B
- HTS Code
- Subscribe to View HTS Code
End Users 6505-01-364-2271
- MOE Rule:
- V540
- Effective Date:
- 1 Apr 1991
Approved Sources 6505-01-364-2271
- Part Number
- Manufacturer
- Status
- 77252
- Manufacturer
- 0PFX4 - Roche Laboratories Inc (Active)
- Primary Buy
- Primary Buy
- NDC00004-0220-01
- 0PFX4 - Roche Laboratories Inc (Active)
- Primary Buy
- Primary Buy
Datasheet 6505-01-364-2271
- Characteristic
- Specifications
- FIIG
- Specifications
- A510N0
- Primary Container Type [CQCT]
- Bottle
- Primary Container Content Quantity [CRLK]
- 100.000 Tablets
- Special Features [FEAT]
- 0.375 Mg;Oval;Film Coated
Similar Supply Items to 6505-01-364-2271
Freight Information 6505-01-364-2271
6505-01-364-2271 has freight characteristics.. 6505-01-364-2271 has a variance between NMFC and UFC when transported by rail and the description should be consulted.